newsfilter
← Latest News
PR Newswire·

Fusion Pharmaceuticals Shareholders Approve Acquisition by AstraZeneca

Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as...